BRCA1 and triple-negative breast carcinoma: The National Comprehensive Cancer Network (NCCN) has recommended various guidelines for the genetic testing of BRCA1 and BRCA2, which include specific criteria on the age at diagnosis of the patients and family members; the occurrence of breast, ovarian, pancreatic or prostate cancer in close relatives; and the diagnosis of triple-negative breast cancer (TNBC) [1].